Kate Pinner

Hatfield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A plain language summary: an overview of objective (scientific) data and patient experiences showing how effective lemborexant is for treating insomnia.

A plain language summary: an overview of objective (scientific) data and patient experiences showing how effective lemborexant is for treating insomnia.

Journal: Postgraduate medicine

Published: July 20, 2026

Consistency of objective and subjective evidence for the efficacy of lemborexant.

Consistency of objective and subjective evidence for the efficacy of lemborexant.

Journal: Postgraduate medicine

Published: January 08, 2026

Effects of lemborexant on sleep quality and its association with morning alertness: Post hoc analysis of two phase 3 trials.

Effects of lemborexant on sleep quality and its association with morning alertness: Post hoc analysis of two phase 3 trials.

Journal: Sleep medicine: X

Published: December 22, 2025

Effect of Lemborexant on Daytime Functioning in Adults With Insomnia: Patient-Reported Outcomes From a Phase 3 Clinical Trial.

Effect of Lemborexant on Daytime Functioning in Adults With Insomnia: Patient-Reported Outcomes From a Phase 3 Clinical Trial.

Journal: The primary care companion for CNS disorders

Published: January 17, 2025

Perception of Lemborexant Effectiveness as Assessed by the Patient Global Impression-Insomnia Questionnaire.

Perception of Lemborexant Effectiveness as Assessed by the Patient Global Impression-Insomnia Questionnaire.

Journal: Nature and science of sleep

Published: October 12, 2024

Comment on Watson et al. Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia. J. Clin. Med. 2023, 12, 2493.

Comment on Watson et al. Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia. J. Clin. Med. 2023, 12, 2493.

Journal: Journal of clinical medicine

Published: May 02, 2024

Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms.

Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms.

Journal: Neuropsychopharmacology reports

Published: April 09, 2024

Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder.

Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder.

Journal: Neurology and therapy

Published: January 20, 2024

Efficacy and safety of lemborexant in midlife women with insomnia disorder.

Efficacy and safety of lemborexant in midlife women with insomnia disorder.

Journal: Menopause (New York, N.Y.)

Published: June 20, 2023

Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study.

Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study.

Journal: Sleep medicine

Published: April 21, 2023

Effect of discontinuation of lemborexant following long-term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial.

Effect of discontinuation of lemborexant following long-term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial.

Journal: Clinical and translational science

Published: August 18, 2022

Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder.

Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder.

Journal: Postgraduate medicine

Published: March 07, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026